Podoxetil Tablet (Cefpodoxime Proxetil)

Adult dose

Adults: Administer cefpodoxime 100mg (potency) orally twice daily after meals. For severe infections or when the response is considered inadequate, administer 200mg (potency) orally twice daily after meals. The dose may be adjusted appropriately according to age, symptoms, etc.

This medication should not be used in patients who have previously experienced shock symptoms as a result of this drug. This medication contains lactose; therefore, it should not be administered to patients who have problems with lactose digestion or certain genetic metabolic disorders. Patients with a history of allergy to this medication's components or similar classes of antibiotics should be particularly cautious, and administration should be avoided if possible. Patients with a history of allergic reactions to penicillin antibiotics should also use this medication with caution. Patients with a constitution prone to allergic reactions such as bronchial asthma or skin rashes, urticaria should be carefully monitored when taking this medication. Patients with severely impaired kidney function may have delayed elimination of this medication; thus, dosage adjustment and monitoring of their condition are important. Patients who cannot take medications orally, those in poor nutritional status, and elderly patients should be closely monitored for signs of vitamin K deficiency. This medication can rarely cause severe allergic reactions or shock; therefore, if symptoms such as discomfort, oral abnormalities, shortness of breath, or dizziness occur during administration, the medication should be discontinued immediately. If hypersensitivity reactions such as skin rashes, urticaria, itching, or fever occur, administration should be stopped, and appropriate treatment should be received. Gastrointestinal symptoms may include abdominal pain, diarrhea, nausea, and vomiting; if severe diarrhea or bloody stools occur, the use of the medication should be discontinued immediately. If respiratory symptoms such as dyspnea, cough, or fever arise, the medication should be stopped and corticosteroid treatment should be administered if necessary. Blood tests may reveal leukopenia or platelet abnormalities, so regular blood tests are required for prolonged use. Neurological disturbances such as cognitive impairment, behavioral changes, or seizures may occur and are more commonly seen in patients with poor kidney function. Severe skin disorders can rarely occur, so the skin condition should be monitored closely. Liver function test results may increase; therefore, regular liver function tests are recommended. If there are signs of kidney dysfunction, administration should be stopped immediately, and appropriate treatment should be received. Phenomena such as oral mucositis or candidiasis may occur. Rarely, bleeding tendencies due to vitamin K deficiency or symptoms of vitamin B complex deficiency may appear; therefore, caution should be taken. To prevent the creation of resistant bacteria when using this medication, susceptibility tests should be performed, and it is recommended to administer it for only the minimum necessary duration. It is advisable to conduct thorough interviews and skin reaction tests before administration. Dizziness may occur, so caution is needed when driving or operating machinery. If used for more than 10 days, a blood test should be conducted to check leukocyte levels. In patients with decreased kidney function, seizure risks may occur without dose adjustment; thus, careful monitoring is needed. This medication may affect kidney function when used in conjunction with certain diuretics or other antibiotics, so caution is required when used together. The concentration of this medication in the body may change when taken with certain drugs, requiring attention during administration. Safety during pregnancy is not established; therefore, pregnant or potentially pregnant women should use this medication only when its benefits exceed the risks. It is recommended that breastfeeding women discontinue breastfeeding, as this medication may be secreted in breast milk. The safety for children, especially newborns or premature infants, has not been fully confirmed, so it should be used with caution. Elderly patients are at higher risk for bleeding due to decreased physical function and vitamin K deficiency, so dosages and intervals should be adjusted while closely monitoring their condition. This medication can affect certain clinical test results, so it's important to inform the medical staff during testing.

• shock
• anaphylactic reaction
• discomfort
• oral dysesthesia
• wheezing
• dizziness
• stool changes
• tinnitus
• sweating
• rash

This medication should be stored in a tightly closed container to prevent air or moisture intrusion, and the storage temperature should be maintained between 1°C and 30°C at room temperature. This way, the medication's effectiveness can be well preserved.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle